Duquesne Family Office’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
2022
Q4
$2.24M Hold
2022
Q3
$1.48M Hold
2022
Q2
$1.79M Hold
2022
Q1
$1.93M Sell
2021
Q4
$10.7M Sell
2021
Q3
$69.9M Buy
2021
Q2
$90.2M Sell
2021
Q1
$74.8M Hold
2020
Q4
$92.7M Buy
2020
Q3
$53M Buy
2020
Q2
$83.1M Buy
2020
Q1
$76.8M Buy
2019
Q4
$87.2M Buy
2019
Q3
$13.9M Buy